FOLD Amicus Therapeutics Inc

Amicus Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of next-generation medicines.

$10.27  +0.23 (2.29%)
As of 06/24/2021 15:59:49 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/31/2007
Outstanding shares:  266,060,455
Average volume:  2,555,410
Market cap:   $2,631,337,900
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    03152W109
ISIN:        US03152W1099
Sedol:      B19FQ48
Valuation   (See tab for details)
PE ratio:   -10.53
PB ratio:   10.65
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy